Jul 9, 2025 09:46AM
Jun 11, 2025 05:34AM
May 30, 2025 08:44AM
May 21, 2025 06:00AM
Feb 21, 2025 06:09AM
Jan 7, 2025 06:02AM
Jan 7, 2025 06:00AM Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights
Nov 5, 2024 02:00AM
Nov 8, 2023 02:00AM
May 24, 2023 02:00AM
Dec 20, 2022 12:49PM
Nov 2, 2022 03:00AM
Aug 15, 2022 04:05PM
Aug 11, 2022 05:35AM Verona Pharma plc (VRNA) Pricing Upsized 12.4M Share Offering at $10.50/sh
Aug 10, 2022 08:22PM
Aug 9, 2022 04:19PM
Aug 9, 2022 04:16PM
May 25, 2022 02:00AM
Nov 1, 2021 03:00AM
May 25, 2021 02:00AM
Nov 9, 2020 02:00AM Verona Pharma Announces November 2020 Virtual Investor Conference Participation
Nov 9, 2020 02:00AM
Aug 25, 2020 04:53AM
Jul 17, 2020 07:55AM
Jul 17, 2020 02:00AM
Jul 17, 2020 02:00AM
Nov 13, 2019 02:00AM
Nov 13, 2019 02:00AM Verona Pharma to Present at Jefferies 2019 London Healthcare Conference
May 30, 2019 02:00AM
May 30, 2019 02:00AM
May 30, 2018 08:30AM
Oct 31, 2017 02:55AM
May 23, 2017 08:30AM
May 22, 2017 06:09AM
May 18, 2017 02:09PM Verona Pharma Announces Closing of Exercise of Underwriters’ Over-allotment Option
May 2, 2017 01:53PM
Apr 26, 2017 11:13PM

69,742 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All